Red Arrow Therapeutics Raises $4.5M for Lead Compound Research and Manufacturing

Red Arrow Therapeutics' Seed Extension Funding

Key Highlights:

• Seed Extension Funding: Red Arrow Therapeutics, a developer of pH-sensing nanomedicine drug delivery technologies, closed a $4.5 million Seed Extension round.
• Lead Compound: The funding will support obtaining key preclinical data on the safety and efficacy of Red Arrow Therapeutics' lead compound, IL-12-loaded nanopolymeric micelles.
• Manufacturing Collaboration: The funding will also enable the initiation of manufacturing in collaboration with external partners.

Red Arrow Therapeutics' Target Market

• Target Market: Pharmaceutical companies and researchers in need of advanced drug delivery technologies for various therapeutic areas, with a focus on oncology.
• Research Institutions and Universities: Collaborations with research institutions and universities for further development and validation of their pH-sensing nanomedicine drug delivery technologies.
• Pharmaceutical Manufacturing Partners: Partnerships with pharmaceutical manufacturing companies for the production and distribution of their nanopolymeric micelles.

What Red Arrow Therapeutics Needs to Buy

• Research and Development Services: Collaborations with research organizations and universities for further development and validation of their drug delivery technologies.
• Manufacturing Partnerships: Partnerships with pharmaceutical manufacturing companies for the production and distribution of their nanopolymeric micelles.
• Marketing and Sales Support: Services to support marketing and sales efforts, including market research, branding, and customer acquisition strategies.